MedTrace Logo

Outpatient Treatment of Low-risk Pulmonary Embolism

NCT02355548 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-11-29

No results posted yet for this study

Summary

This study is looking at the safety and effectiveness of treating Patients diagnosed with a low-risk Pulmonary Embolism (PE) in an outpatient setting instead of the standard, in-patient hospitalization. Patients have several medical tests done during their Emergency Department visit. Based on those tests, those who are determined to have a low-risk PE are eligible to participate in the study. Those choosing to participate are discharged after 12 hours of medical observation. Patients who choose to participate are followed up by telephone approximately 90 days later.

Conditions

Interventions

OTHER

Outpatient Treatment of Pulmonary Embolism

Patients who participate in the study will be treated for their pulmonary embolism in an outpatient setting instead of being hospitalized.

Sponsors & Collaborators

  • Intermountain Health Care, Inc.

    lead OTHER

Principal Investigators

  • Joseph Bledsoe, MD · Intermountain Health Care, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02355548 on ClinicalTrials.gov